TRiP research group


Dr. Bettina Lange, MD

Research interests/ Focus of work:
Schizophrenia, Endocannabinoid system, Clinical Trials

Academic education:
2005 – 2011 Study of Medicine, Eberhardt-Karls-University Tuebingen
2011 Medical license
Doctoral thesis:
2014 „Modification of the gut microbiome by vegetarian diet", Eberhardt-Karls-University Tuebingen
Professional experience:
2012 - 2014 Resident, Dept. of Neurology, University Hospital Giessen and Marburg, Marburg
since 2014 Resident, Dept. of Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim (maternal leave 2017-2018)
2017 B. Lange, J. K. Mueller, F. M. Leweke, J. M. Bumb (2017) How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review. Expert Opin Pharmacother 18:351-362
2016 F. M. Leweke, J. K. Mueller, B. Lange, C. Rohleder: Therapeutic potential of cannabinoids in psychosis. Biol Psychiatry 79:604-612